EPSRC IAA 22-25: Pioneering A Novel Cancer Targeting Glyco-immunotherapy Strategy

Project: Other project (funded) › Restricted grant

Project Details

StatusActive
Effective start/end date1/04/24 → 30/09/24

Funding

  • EPSRC: £29,562.12